6
Oct
2026

AMW

Exhibitor at CPHI Milan 2026 stand 16C74, Finished Dosage & Formulation
About Us

AMW GmbH is a specialty pharmaceutical company focused on biodegradable implants, providing patients and partners access to long-acting value-added medicines for improved adherence and cost-effective therapies. The Company covers the entire value chain, from (co-)development to manufacturing and international commercialization. AMW has two approved medical products, implants releasing goserelin and leuprorelin, which are distributed worldwide via direct sales or through both local and global pharma partners. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2021
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16C74, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Goserelin 10,8mg (3-Month Implant)

    Product Goserelin 10,8mg (3-Month Implant)

    The active ingredient goserelin is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Thus, goserelin intake has indirect effects on testosterone levels in men, the lowering of which stops the growth of malignant cancerous tumors. In a...
  • Goserelin 3,6mg (1-Month Implant)

    Product Goserelin 3,6mg (1-Month Implant)

    The active ingredient goserelin is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Thus, goserelin intake has indirect effects on testosterone levels in men, the lowering of which stops the growth of malignant cancerous tumors. In a...
  • Leuprolide 3-Month Implant

    Product Leuprolide 3-Month Implant

    The active ingredient leuprorelin, like goserelin, is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Administration of leuprorelin has indirect effects on testosterone levels in men, the lowering of which stops the growth of malign...